Therefore, we assessed the expression level of CDK2 based on RNA-seq datasets and found that CDK2 mRNA expression level increased significantly in AML cohort in comparison with whole blood samples in normal cohort (p < 0.0001) (Figs. 2A and S4A). This evidence concerns the gene CDK2 and acute myeloid leukemia.